The West Australian |
Prospect of generic asthma drug Advair hits Glaxo
Philly.com GlaxoSmithKline P.L.C.'s top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue, but generic competition got a bit closer to reality this week. Advair is delivered to patients through an inhaler … Mylan shares jump after FDA lays out guidelines for asthma generic FDA Offers Guidance for Advair Knockoffs Glaxo May Face Generic Advair Sooner Than Expected |
View full post on asthma – Google News